Differential Addictive Potential of Cis- and Trans-3-Methylfentanyl Revealed by Pharmacokinetic-Pharmacodynamic Profiling
Clicks: 4
ID: 317275
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #35 of 49 articles by views in journal of analytical toxicology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Rationale 3-Methylfentanyl (3-MF) is a highly potent synthetic opioid linked to a high risk of overdose. Although its analgesic effects are known to be stereoselective, the differences in addictive potential between its cis- and trans-isomers have not been fully elucidated. Objectives This study aimed to compare the abuse liability of cis- and trans-3-MF isomers using behavioral, pharmacokinetic, neurochemical, and transporter-based evaluations in rodents. Methods Conditioned place preference (CPP) was used to assess addiction potential in rodents. Pharmacokinetic profiles were evaluated in rats via intravenous (iv), intramuscular (im), and subcutaneous (sc) routes. Brain microdialysis measured nucleus accumbens (NAc) exposure and monoamine release. In vitro transporter assays assessed interactions with breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp). Results Cis-3-MF induced CPP at 8-fold lower doses than trans-3-MF (10 vs. 80 µg/kg). Pharmacokinetic analyzes revealed that trans-3-MF had higher plasma exposure after intravenous administration, while cis-3-MF showed nearly 100% bioavailability via intramuscular or subcutaneous routes. Microdialysis demonstrated 2.7-fold greater nucleus accumbens exposure of cis-3-MF and a more rapid and pronounced DA release (Cmax: 67 vs. 37 ng/mL for trans-3-MF). In contrast, trans-3-MF induced a slower increase in DA but elevated 5-HT levels. Trans-3-MF was identified as a partial BCRP substrate, potentially limiting brain penetration. Neither isomer interacted significantly with P-gp. Conclusions Stereochemistry critically influences the addictive potential of 3-MF isomers. Cis-3-MF demonstrates greater abuse liability, driven by enhanced brain exposure and dopaminergic activation. These findings contribute to understanding stereoselective risks in synthetic opioid toxicity and support improved safety evaluations for novel analogs.
| Reference Key |
openalex_W7164855724
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Xin Bai, Yao Chen, Zi-Qing Wei, Jing Bian, Zhou Chuan-ming, Lihong Lv, Hui Zheng, Yanbiao Zhao, Yi Rao, Zhi-ru Xu |
| Journal | journal of analytical toxicology |
| Year | 2026 |
| DOI |
10.1093/jat/bkag049
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.